Australia: TGA Approval and PBS Subsidy Rules
Australia's Therapeutic Goods Administration approves GLP-1 drugs, but Pharmaceutical Benefits Scheme subsidy is a separate, additional decision that determines affordability.
By the GLP Semaglutide editorial team · Last updated March 14, 2026
The Therapeutic Goods Administration (TGA) is responsible for approving medicines for supply in Australia, including GLP-1 drugs, based on safety, quality, and efficacy review similar in structure to the FDA and EMA processes.
PBS listing is a separate, major cost factor
TGA approval alone doesn't guarantee affordable access — the Pharmaceutical Benefits Scheme (PBS) separately decides which approved drugs receive government subsidy, and PBS listing status has been a significant factor in out-of-pocket cost for GLP-1 drugs used specifically for weight management in Australia.
Where to check current listing
The PBS website publishes current subsidized medicines and eligibility criteria directly, and is the authoritative source for whether a specific GLP-1 drug and indication is subsidized at a given time.
Primary sources